Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
- 23 March 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 337 (8743) , 690-694
- https://doi.org/10.1016/0140-6736(91)90277-v
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effect of the oral leukotriene D antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D in atopic subjectsJournal of Allergy and Clinical Immunology, 1989
- The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjectsJournal of Allergy and Clinical Immunology, 1988
- Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man.Thorax, 1987
- The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man*1Journal of Allergy and Clinical Immunology, 1987
- The origin of airway hyperresponsivenessJournal of Allergy and Clinical Immunology, 1986
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984
- Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapyJAMA, 1983
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposureJournal of Allergy and Clinical Immunology, 1983
- Bronchial reactivity to inhaled histamine: a method and clinical surveyClinical and Experimental Allergy, 1977